Allison Boboltz

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Pseudomonas Aeruginosa

Cystic Fibrosis

Top Venues

RSC pharmaceutics

Science advances

Journal of materials chemistry. B

This page only lists publications with an associated author ORCID identifier.

Publications

Harry Zou, Allison Boboltz, Yahya Cheema, Daniel Song, Devorah Cahn, Gregg A Duncan
Synthetic mucus barrier arrays as a nanoparticle formulation screening platform. RSC pharmaceutics 1 (2) (2024)
Harry Zou, Allison Boboltz, Yahya Cheema, Daniel Song, Devorah Cahn, Gregg A Duncan
Synthetic mucus barrier arrays as a nanoparticle formulation screening platform. RSC pharmaceutics 1 (2) (2024)
Harry Zou, Allison Boboltz, Yahya Cheema, Daniel Song, Devorah Cahn, Gregg A Duncan
Synthetic mucus barrier arrays as a nanoparticle formulation screening platform. RSC pharmaceutics 1 (2) (2024)
Allison Boboltz, Sydney Yang, Gregg A Duncan
Engineering in vitro models of cystic fibrosis lung disease using neutrophil extracellular trap inspired biomaterials. Journal of materials chemistry. B (2023)
Daniel Song, Ethan Iverson, Logan Kaler, Allison Boboltz, Margaret A Scull, Gregg A Duncan
MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. Science advances 8 (47) (2022)